Assenagon Asset Management S.A. Increases Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Assenagon Asset Management S.A. boosted its position in Mettler-Toledo International Inc. (NYSE:MTD) by 19.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 38,717 shares of the medical instruments supplier’s stock after buying an additional 6,387 shares during the period. Assenagon Asset Management S.A.’s holdings in Mettler-Toledo International were worth $47,377,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently bought and sold shares of MTD. State Street Corp boosted its holdings in shares of Mettler-Toledo International by 1.0% in the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after acquiring an additional 9,009 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Mettler-Toledo International by 0.8% in the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after purchasing an additional 4,166 shares during the last quarter. Barclays PLC grew its position in Mettler-Toledo International by 8.3% during the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock worth $384,822,000 after purchasing an additional 19,609 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after buying an additional 28,478 shares during the last quarter. Finally, Loomis Sayles & Co. L P boosted its stake in shares of Mettler-Toledo International by 1.8% in the third quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock worth $314,790,000 after buying an additional 3,644 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Up 0.6 %

MTD opened at $1,278.98 on Thursday. The company has a market cap of $26.99 billion, a PE ratio of 34.48, a price-to-earnings-growth ratio of 4.21 and a beta of 1.12. Mettler-Toledo International Inc. has a twelve month low of $1,133.46 and a twelve month high of $1,546.93. The company has a 50-day moving average price of $1,246.46 and a 200 day moving average price of $1,345.43.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The business had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. As a group, sell-side analysts expect that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts recently weighed in on MTD shares. Wolfe Research assumed coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating for the company. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and boosted their target price for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Robert W. Baird dropped their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Evercore ISI upgraded shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and upped their price objective for the stock from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Finally, Wells Fargo & Company dropped their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. One analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $1,351.25.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now directly owns 6 shares of the company’s stock, valued at $7,524.54. This trade represents a 95.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now owns 240 shares of the company’s stock, valued at $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.